Back to Search
Start Over
Naringenin Nano-Delivery Systems and Their Therapeutic Applications
- Source :
- Pharmaceutics, Vol 13, Iss 291, p 291 (2021), Pharmaceutics
- Publication Year :
- 2021
- Publisher :
- MDPI AG, 2021.
-
Abstract
- Naringenin (NRG) is a polyphenolic phytochemical belonging to the class of flavanones and is widely distributed in citrus fruits and some other fruits such as bergamot, tomatoes, cocoa, and cherries. NRG presents several interesting pharmacological properties, such as anti-cancer, anti-oxidant, and anti-inflammatory activities. However, the therapeutic potential of NRG is hampered due to its hydrophobic nature, which leads to poor bioavailability. Here, we review a wide range of nanocarriers that have been used as delivery systems for NRG, including polymeric nanoparticles, micelles, liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nanosuspensions, and nanoemulsions. These nanomedicine formulations of NRG have been applied as a potential treatment for several diseases, using a wide range of in vitro, ex vivo, and in vivo models and different routes of administration. From this review, it can be concluded that NRG is a potential therapeutic option for the treatment of various diseases such as cancer, neurological disorders, liver diseases, ocular disorders, inflammatory diseases, skin diseases, and diabetes when formulated in the appropriate nanocarriers.
- Subjects :
- Naringenin
natural products
naringenin
lcsh:RS1-441
Pharmaceutical Science
Review
02 engineering and technology
Pharmacology
lcsh:Pharmacy and materia medica
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Nutraceutical
Solid lipid nanoparticle
flavonoid
nutraceuticals
Liposome
Chemistry
food and beverages
021001 nanoscience & nanotechnology
nanomedicine
Bioavailability
antioxidants
030220 oncology & carcinogenesis
drug delivery
Drug delivery
Nanomedicine
nanoparticles
Nanocarriers
bioavailability
0210 nano-technology
Subjects
Details
- ISSN :
- 19994923
- Volume :
- 13
- Database :
- OpenAIRE
- Journal :
- Pharmaceutics
- Accession number :
- edsair.doi.dedup.....dd6bea3c01b30bdcd6c9c253542b2735